This is a preview of subscription content, log in via an institution to check access.
Notes
incremental cost-effectiveness ratio
Reference
Ronaldson S, et al. Economic evaluation of SQ-standardized grass allergy immunotherapy tablet (Grazax) in children. Internet Document : 14 Apr 2014. Available from: URL: http://dx.doi.org/10.2147/CEOR.S44079
Rights and permissions
About this article
Cite this article
Grazax a cost effective option for treating pollen allergy in UK. PharmacoEcon Outcomes News 701, 4 (2014). https://doi.org/10.1007/s40274-014-1196-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-014-1196-1